Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerzy-Roch Nofer

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Plos One|August 28, 2015
Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) MiceJan Larmann, Kerstin Jurk, Henrike Janssen, et al.
Journal of Lipid Research|May 7, 2010
Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptorsChristian H Schweppe, Petra Hoffmann, Jerzy-Roch Nofer, et al.
Journal of Occupational Health|March 5, 2015
Scintigraphic assessment of renal function in steel plant workers occupationally exposed to leadTeresa Wrońska-Nofer, Anna Pisarska, Małgorzata Trzcinka-Ochocka, et al.
Pharmaceuticals (Basel, Switzerland)|October 14, 2020
Impact of S1P Mimetics on Mesenteric Ischemia/Reperfusion InjuryFrancesco Potì, Carmine Giorgio, Irene Zini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 4, 2013
KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- miceFrancesco Potì, Fabio Gualtieri, Sandro Sacchi, et al.
Thrombosis and Haemostasis|January 12, 2012
Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) miceFrancesco Poti, Martine Bot, Sara Costa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 1, 2006
Evidence for oxidative stress at elevated plasma thiol levels in chronic exposure to carbon disulfide (CS2) and coronary heart diseaseTeresa Wronska-Nofer, Jerzy-Roch Nofer, Jan Stetkiewicz, et al.
Atherosclerosis|December 31, 2016
High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expressionRenata Feuerborn, Susen Becker, Francesco Potì, et al.
The Journal of Biological Chemistry|May 28, 2004
Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease)Jerzy-Roch Nofer, Grazyna Herminghaus, Martin Brodde, et al.
Circulation|January 24, 2007
FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient miceJerzy-Roch Nofer, Martine Bot, Martin Brodde, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Plos One|August 28, 2015
Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) MiceJan Larmann, Kerstin Jurk, Henrike Janssen, et al.
Journal of Lipid Research|May 7, 2010
Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptorsChristian H Schweppe, Petra Hoffmann, Jerzy-Roch Nofer, et al.
Journal of Occupational Health|March 5, 2015
Scintigraphic assessment of renal function in steel plant workers occupationally exposed to leadTeresa Wrońska-Nofer, Anna Pisarska, Małgorzata Trzcinka-Ochocka, et al.
Pharmaceuticals (Basel, Switzerland)|October 14, 2020
Impact of S1P Mimetics on Mesenteric Ischemia/Reperfusion InjuryFrancesco Potì, Carmine Giorgio, Irene Zini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 4, 2013
KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- miceFrancesco Potì, Fabio Gualtieri, Sandro Sacchi, et al.
Thrombosis and Haemostasis|January 12, 2012
Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) miceFrancesco Poti, Martine Bot, Sara Costa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 1, 2006
Evidence for oxidative stress at elevated plasma thiol levels in chronic exposure to carbon disulfide (CS2) and coronary heart diseaseTeresa Wronska-Nofer, Jerzy-Roch Nofer, Jan Stetkiewicz, et al.
Atherosclerosis|December 31, 2016
High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expressionRenata Feuerborn, Susen Becker, Francesco Potì, et al.
The Journal of Biological Chemistry|May 28, 2004
Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease)Jerzy-Roch Nofer, Grazyna Herminghaus, Martin Brodde, et al.
Circulation|January 24, 2007
FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient miceJerzy-Roch Nofer, Martine Bot, Martin Brodde, et al.
Pageof 10